Amplification of dopaminergic signaling by a positive feedback loop

被引:196
作者
Nishi, A
Bibb, JA
Snyder, GL
Higashi, H
Nairn, AC
Greengard, P
机构
[1] Kurume Univ, Sch Med, Dept Physiol, Fukuoka 8300011, Japan
[2] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA
关键词
D O I
10.1073/pnas.220410397
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dopamine and cAMP-regulated phosphoprotein of M-r 32,000 (DARPP-32) plays an obligatory role in most of the actions of dopamine. in resting neostriatal slices, cyclin-dependent kinase 5 (Cdk5) phosphorylates DARPP-32 at Thr-75. thereby reducing the efficacy of dopaminergic signaling. We report here that dopamine, in slices, and acute cocaine, in whole animals, decreases the state of phosphorylation of striatal DARPP-32 at Thr-75 and thereby removes this inhibitory constraint. This effect of dopamine is achieved through dopamine D1 receptor-mediated activation of cAMP-dependent protein kinase (PKA). The activated PKA, by decreasing the state of phosphorylation of DARPP-32-Thr-75, deinhibits itself. Dopamine D2 receptor stimulation has the opposite effect. The ability of activated PKA to reduce the state of phosphorylation of DARPP-32-Thr-75 is apparently attributable to increased protein phosphatase-2A activity, with Cdk5 being unaffected. Together, these results indicate that via positive feedback mechanisms, Cdk5 signaling and PKA signaling are mutually antagonistic.
引用
收藏
页码:12840 / 12845
页数:6
相关论文
共 30 条
[1]   cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells [J].
Begum, N ;
Ragolia, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) :31166-31171
[2]   Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons [J].
Bibb, JA ;
Snyder, GL ;
Nishi, A ;
Yan, Z ;
Meijer, L ;
Fienberg, AA ;
Tsai, LH ;
Kwon, YT ;
Girault, JA ;
Czernik, AJ ;
Huganir, RL ;
Hemmings, HC ;
Nairn, AC ;
Greengard, P .
NATURE, 1999, 402 (6762) :669-671
[3]   DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission [J].
Fienberg, AA ;
Hiroi, N ;
Mermelstein, PG ;
Song, WJ ;
Snyder, GL ;
Nishi, A ;
Cheramy, A ;
O'Callaghan, JP ;
Miller, DB ;
Cole, DG ;
Corbett, R ;
Haile, CN ;
Cooper, DC ;
Onn, SP ;
Grace, AA ;
Ouimet, CC ;
White, FJ ;
Hyman, SE ;
Surmeier, DJ ;
Girault, JA ;
Nestler, EJ ;
Greengard, P .
SCIENCE, 1998, 281 (5378) :838-+
[4]   Beyond the dopamine receptor: the DARPP-32/Protein phosphatase-1 cascade [J].
Greengard, P ;
Allen, PB ;
Nairn, AC .
NEURON, 1999, 23 (03) :435-447
[5]   DARPP-32, A DOPAMINE-REGULATED NEURONAL PHOSPHOPROTEIN, IS A POTENT INHIBITOR OF PROTEIN PHOSPHATASE-1 [J].
HEMMINGS, HC ;
GREENGARD, P ;
TUNG, HYL ;
COHEN, P .
NATURE, 1984, 310 (5977) :503-505
[6]  
HEMMINGS HC, 1986, J NEUROSCI, V6, P1469
[7]   Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding [J].
Huang, HB ;
Horiuchi, A ;
Goldberg, J ;
Greengard, P ;
Nairn, AC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3530-3535
[8]   CALYCULIN-A AND OKADAIC ACID - INHIBITORS OF PROTEIN PHOSPHATASE-ACTIVITY [J].
ISHIHARA, H ;
MARTIN, BL ;
BRAUTIGAN, DL ;
KARAKI, H ;
OZAKI, H ;
KATO, Y ;
FUSETANI, N ;
WATABE, S ;
HASHIMOTO, K ;
UEMURA, D ;
HARTSHORNE, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) :871-877
[9]  
Lazaro JB, 1996, NEUROSCI LETT, V218, P21
[10]   The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm [J].
McCright, B ;
Rivers, AM ;
Audlin, S ;
Virshup, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (36) :22081-22089